GSC
ITCI

Ground Swell Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Ground Swell Capital’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$8K Buy
+615
New +$9.24K 0.02% 1203

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Ground Swell Capital's ITCI Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Intra-Cellular Therapies Inc. (ITCI) in Q3 2014: 615 shares worth $8K. The stake represents 0.02% of the portfolio and ranks #1203 among its holdings.

49 funds tracked by Wall St. Rank hold ITCI as of Q3 2014.

  • Ground Swell Capital held 615 shares of Intra-Cellular Therapies Inc. worth $8K as of Q3 2014.
  • Intra-Cellular Therapies Inc. was a new Ground Swell Capital position in Q3 2014.
  • Intra-Cellular Therapies Inc. made up 0.02% of Ground Swell Capital's portfolio in Q3 2014, its #1203 holding.
  • 49 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.